ubmslateOT-logo-ubm

OT mobile menu

Search form

Topics:

Cancer and Genetics

ASCO Calls for Better Regulation, Training and Research for Genetic and Genomic Testing

Oncologists need to be better prepared to interpret and explain gene test results to their patients. Image © vitstudio/ Shutterstock.com

Cancer and Genetics

A new population-based study is suggesting that there are significant racial disparities in gene expression profiling testing in women with breast cancer.

A new study is suggesting that serial genetic changes at the KRAS locus are frequent in cancer and modulate competitive fitness and MEK dependency.

A research team from the United States and Canada have developed and successfully tested new computational software that determines whether a human DNA sample includes an epigenetic add-on linked to cancer and other adverse health conditions.

Researchers at Tulane University are reporting on how cancer is able to overcome p53, a key tumor-suppressing protein.

Oncologists today now have a much greater understanding of the mutational landscape underlying some tumors. However, in many respects it is still a daunting task—one that may require more effective interpretation tools.

Among active or former smokers undergoing lung cancer screening, longer peripheral leukocyte telomere length is associated with an increased risk of lung cancer.

New data are suggesting that deciphering the genomic diversity and evolution of tumors may provide a basis for identifying new targets and designing improved personalized medicine strategies.

Pages

Subscribe to Cancer and Genetics on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.